Table 1. Patient and Disease Characteristics (n=41).
| Variables | Value | |
|---|---|---|
| Age (yr) | 66 (42–84) | |
| <70 | 23 (56.1) | |
| ≥70 | 18 (43.9) | |
| Sex | ||
| Male | 23 (56.1) | |
| Female | 18 (43.9) | |
| Location | ||
| Head/uncinated process | 26 (63.4) | |
| Body/tail | 15 (36.6) | |
| CEA (ng/mL) | 3.2 (0.8–144.8) | |
| CA19-9 (U/mL) | 86 (0.08–15698.3) | |
| Tumor size (clinical, cm) | 3.0 (1.0–8.0) | |
| Pathologic confirm before surgery | ||
| No | 26 (63.4) | |
| Yes | 15 (36.6) | |
| Types of surgery | ||
| PPPD | 26 (63.4) | |
| Distal pancreatectomy | 13 (31.7) | |
| Total pancreatectomy | 2 (4.9) | |
| Pathological T stage | ||
| T1 | 1 (2.4) | |
| T2 | 23 (56.1) | |
| T3 | 17 (41.5) | |
| Pathological N stage | ||
| N0 | 15 (36.6) | |
| N1 | 16 (39.0) | |
| N2 | 10 (24.4) | |
| AJCC stage (8th) | ||
| I | 9 (22.0) | |
| II | 22 (53.7) | |
| III | 10 (24.4) | |
| Histology | ||
| Adenocarcinoma | 39 (95.1) | |
| Others | 2 (4.9) | |
| LVI | ||
| No | 22 (53.7) | |
| Yes | 19 (46.3) | |
| PNI | ||
| No | 6 (14.6) | |
| Yes | 35 (85.4) | |
| Margin status | ||
| Negative | 36 (87.8) | |
| Positive | 5 (12.2) | |
| Degree of resection | ||
| Wide R0 | 31 (75.6) | |
| Narrow R0 | 5 (12.2) | |
| R1 | 5 (12.2) | |
CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; PPPD, pylorus-preserving pancreaticoduodenectomy; AJCC, American Joint Committee on Cancer; LVI, lymphovascular invasion; PNI, perineural invasion.
Data are presented as median (range) or n (%).